| 2023-10-16 | Tango Therapeutics, Inc. TNGX | 500,000 0.5093% | $6.84 | $3.42M | +27.91% | |||
| 2023-10-13 | Tango Therapeutics, Inc. TNGX | 750,000 0.6778% | $7.07 | $5.3M | +8.32% | |||
| 2023-10-09 | Sale | Tango Therapeutics, Inc. TNGX | 225,000 0.2231% | $9.96 | $2.24M | -15.6% | ||
| 2023-08-23 | Sale | iTeos Therapeutics, Inc. ITOS | 350,000 1.1785% | $16.26 | $5.69M | -18.81% | ||
| 2023-08-11 | Tango Therapeutics, Inc. TNGX | 475,000 0.3675% | $5.15 | $2.45M | +9.59% | |||
| 2022-01-04 | Sale | iTeos Therapeutics, Inc. ITOS | 184,677 0.5298% | $42.77 | $7.9M | -46.05% | ||
| 2022-01-03 | Sale | iTeos Therapeutics, Inc. ITOS | 515,323 1.4653% | $47.89 | $24.68M | -52.16% | ||
| 2021-12-17 | Tyra Biosciences, Inc. TYRA | 10 percent owner | 250,000 0.6349% | $13.12 | $3.28M | -28.54% | ||
| 2021-09-17 | Tyra Biosciences, Inc. TYRA | 10 percent owner | 625,000 5.4808% | $16.00 | $10M | -43.6% | ||
| 2020-09-25 | PMV Pharmaceuticals, Inc. PMVP | 1.9M 15.1393% | $18.00 | $34.2M | -7.38% | |||
| 2020-07-28 | iTeos Therapeutics, Inc. ITOS | 10 percent owner | 2.85M 12.2192% | $19.00 | $54.15M | +45.66% | ||
| 2019-03-28 | Sale | Solid Biosciences Inc. SLDB | 10 percent owner | 60,000 0.1715% | $9.53 | $571,800 | -45.05% | |
| 2019-03-27 | Sale | Solid Biosciences Inc. SLDB | 10 percent owner | 115,000 0.3335% | $9.60 | $1.1M | -44.54% | |
| 2019-03-26 | Sale | Solid Biosciences Inc. SLDB | 10 percent owner | 275,000 0.7861% | $10.08 | $2.77M | -47.63% | |
| 2018-11-05 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 60,000 0.2164% | $57.16 | $3.43M | -25.99% | |
| 2018-11-02 | Sale | Esperion Therapeutics, Inc. ESPR | 10 percent owner | 40,000 0.1474% | $55.21 | $2.21M | -21.56% |